|
1.
|
Bingham S and Riboli E: Diet and cancer -
the European prospective investigation into cancer and nutrition.
Nat Rev Cancer. 4:206–215. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Benoist S and Nordlinger B: The role of
preoperative chemotherapy in patients with resectable colorectal
liver metastases. Ann Surg Oncol. 16:2385–2390. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Takeuchi H, Bilchik A, Saha S, et al:
c-MET expression level in primary colon cancer: a predictor of
tumor invasion and lymph node metastases. Clin Cancer Res.
9:1480–1488. 2003.PubMed/NCBI
|
|
4.
|
Matsui S, Osada S, Tomita H, et al:
Clinical significance of aggressive hepatectomy for colorectal
liver metastasis, evaluated from the HGF/c-Met pathway. Int J
Oncol. 37:289–297. 2010.PubMed/NCBI
|
|
5.
|
Bates RC and Mercurio AM: The
epithelial-mesenchymal transition (EMT) and colorectal cancer
progression. Cancer Biol Ther. 4:365–370. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Zavadil J and Bottinger EP: TGF-beta and
epithelial-to-mesenchymal transitions. Oncogene. 24:5764–5774.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Derynck R and Zhang YE: Smad-dependent and
Smad-independent pathways in TGF-beta family signalling. Nature.
425:577–584. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Bierie B and Moses HL: Tumour
microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer.
Nat Rev Cancer. 6:506–520. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Zhang B, Halder SK, Zhang S and Datta PK:
Targeting transforming growth factor-beta signaling in liver
metastasis of colon cancer. Cancer Lett. 277:114–120. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Chang HY, Kao MC, Way TD, Ho CT and Fu E:
Diosgenin suppresses hepatocyte growth factor (HGF)-induced
epithelialmesenchymal transition by down-regulation of Mdm2 and
vimentin. J Agric Food Chem. 59:5357–5363. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Osada S, Tomita H, Tanaka Y, et al: The
utility of vitamin K3 (menadione) against pancreatic cancer.
Anticancer Res. 28:45–50. 2008.PubMed/NCBI
|
|
12.
|
Osada S, Sakashita F, Hosono Y, et al:
Extracellular signal-regulated kinase phosphorylation due to
menadione-induced arylation mediates growth inhibition of pancreas
cancer cells. Cancer Chemother Pharmacol. 62:315–320. 2008.
View Article : Google Scholar
|
|
13.
|
Osada S, Saji S and Osada K: Critical role
of extracellular signal-regulated kinase phosphorylation on
menadione (vitamin K3) induced growth inhibition. Cancer.
91:1156–1165. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Osada S and Carr BI: Mechanism of novel
vitamin K analog induced growth inhibition in human hepatoma cell
line. J Hepatol. 34:676–682. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Osada S, Osada K and Carr BI: Tumor cell
growth inhibition and extracellular signal-regulated kinase (ERK)
phosphorylation by novel K vitamins. J Mol Biol. 314:765–772. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Osada S, Sakashita F, Katoh H, Sugiyama Y
and Adachi Y: Identification of an immune tolerance reaction in
response to pretreatment with frozen pancreatic tissue in islet
cell transplantation in rats. Pancreas. 30:e29–e33. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Osada S, Imai H, Tomita H, et al: Vascular
endothelial growth factor protects hepatoma cells against oxidative
stress-induced cell death. J Gastroenterol Hepatol. 21:988–993.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Thiery JP: Epithelial-mesenchymal
transitions in tumour progression. Nat Rev Cancer. 2:442–454. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Wilmanns C, Steinhauer S, Grossmann J and
Ruf G: Site-dependent differences in clinical, pathohistological,
and molecular parameters in metastatic colon cancer. Int J Biol
Sci. 5:458–465. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Tsuji T, Ibaragi S, Shima K, et al:
Epithelial-mesenchymal transition induced by growth suppressor
p12CDK2-AP1 promotes tumor cell local invasion but suppresses
distant colony growth. Cancer Res. 68:10377–10386. 2008. View Article : Google Scholar
|
|
21.
|
Lee JM, Dedhar S, Kalluri R and Thompson
EW: The epithelialmesenchymal transition: new insights in
signaling, development, and disease. J Cell Biol. 172:973–981.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Kang Y and Massague J:
Epithelial-mesenchymal transitions: twist in development and
metastasis. Cell. 118:277–279. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Wu Y and Zhou BP: New insights of
epithelial-mesenchymal transition in cancer metastasis. Acta
Biochim Biophys Sin. 40:643–650. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Xie LQ, Bian LJ, Li Z, Li Y, Li ZX and Li
B: Altered expression of E-cadherin by hepatocyte growth factor and
effect on the prognosis of nasopharyngeal carcinoma. Ann Surg
Oncol. 17:1927–1936. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Walsh LA and Damjanovski S: IGF-1
increases invasive potential of MCF 7 breast cancer cells and
induces activation of latent TGF-beta1 resulting in epithelial to
mesenchymal transition. Cell Commun Signal. 9:102011. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Ding W, You H, Dang H, et al:
Epithelial-to-mesenchymal transition of murine liver tumor cells
promotes invasion. Hepatology. 52:945–953. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Ogunwobi OO and Liu C: Hepatocyte growth
factor upregulation promotes carcinogenesis and
epithelial-mesenchymal transition in hepatocellular carcinoma via
Akt and COX-2 pathways. Clin Exp Metastasis. 28:721–731. 2011.
View Article : Google Scholar
|
|
28.
|
Nawshad A, Lagamba D, Polad A and Hay ED:
Transforming growth factor-beta signaling during
epithelial-mesenchymal transformation: implications for
embryogenesis and tumor metastasis. Cells Tissues Organs.
179:11–23. 2005. View Article : Google Scholar
|
|
29.
|
Peinado H, Olmeda D and Cano A: Snail, Zeb
and bHLH factors in tumour progression: an alliance against the
epithelial phenotype? Nat Rev Cancer. 7:415–428. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Pon YL, Zhou HY, Cheung AN, Ngan HY and
Wong AS: p70 S6 kinase promotes epithelial to mesenchymal
transition through snail induction in ovarian cancer cells. Cancer
Res. 68:6524–6532. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Miyazono K: Transforming growth factor-β
signaling in epithelialmesenchymal transition and progression of
cancer. Proc the Japan Academy, Series B. 85:314–323. 2009.
|
|
32.
|
Trusolino L, Bertotti A and Comoglio PM:
MET signalling: principles and functions in development, organ
regeneration and cancer. Nat Rev Mol Cell Biol. 11:834–848. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Larue L and Bellacosa A:
Epithelial-mesenchymal transition in development and cancer: role
of phosphatidylinositol 3′ kinase/AKT pathways. Oncogene.
24:7443–7454. 2005.
|
|
34.
|
Vincan E and Barker N: The upstream
components of the Wnt signalling pathway in the dynamic EMT and MET
associated with colorectal cancer progression. Clin Exp Metastasis.
25:657–663. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35.
|
Karhadkar SS, Bova GS, Abdallah N, et al:
Hedgehog signalling in prostate regeneration, neoplasia and
metastasis. Nature. 431:707–712. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
36.
|
Wang Z, Banerjee S, Li Y, Rahman KM, Zhang
Y and Sarkar FH: Down-regulation of notch-1 inhibits invasion by
inactivation of nuclear factor-kappaB, vascular endothelial growth
factor, and matrix metalloproteinase-9 in pancreatic cancer cells.
Cancer Res. 66:2778–2784. 2006. View Article : Google Scholar
|
|
37.
|
Fuxe J, Vincent T and Garcia de Herreros
A: Transcriptional crosstalk between TGF-beta and stem cell
pathways in tumor cell invasion: role of EMT promoting Smad
complexes. Cell Cycle. 9:2363–2374. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38.
|
Creighton CJ, Chang JC and Rosen JM:
Epithelial-mesenchymal transition (EMT) in tumor-initiating cells
and its clinical implications in breast cancer. J Mammary Gland
Biol Neoplasia. 15:253–260. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39.
|
Mani SA, Guo W, Liao MJ, et al: The
epithelial-mesenchymal transition generates cells with properties
of stem cells. Cell. 133:704–715. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
40.
|
Singh A and Settleman J: EMT, cancer stem
cells and drug resistance: an emerging axis of evil in the war on
cancer. Oncogene. 29:4741–4751. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
41.
|
Kajiyama H, Shibata K, Terauchi M, et al:
Chemoresistance to paclitaxel induces epithelial-mesenchymal
transition and enhances metastatic potential for epithelial ovarian
carcinoma cells. Int J Oncol. 31:277–283. 2007.
|
|
42.
|
Yang AD, Fan F, Camp ER, et al: Chronic
oxaliplatin resistance induces epithelial-to-mesenchymal transition
in colorectal cancer cell lines. Clin Cancer Res. 12:4147–4153.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
43.
|
Tanahashi T, Osada S, Imai H, et al:
Signal transduction of vitamin K3 for pancreas cancer therapy.
Oncol Rev. 5:57–60. 2010. View Article : Google Scholar
|
|
44.
|
Radisky DC, Levy DD, Littlepage LE, et al:
Rac1b and reactive oxygen species mediate MMP-3-induced EMT and
genomic instability. Nature. 436:123–127. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
45.
|
Matsubara D, Ishikawa S, Oguni S,
Aburatani H, Fukayama M and Niki T: Molecular predictors of
sensitivity to the MET inhibitor PHA665752 in lung carcinoma cells.
J Thorac Oncol. 5:1317–1324. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
46.
|
Koo JS, Jung W and Jeong J: The predictive
role of E-cadherin and androgen receptor on in vitro
chemosensitivity in triple-negative breast cancer. Jpn J Clin
Oncol. 39:560–568. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
47.
|
Nakamura T, Kato Y, Fuji H, Horiuchi T,
Chiba Y and Tanaka K: E-cadherin-dependent intercellular adhesion
enhances chemoresistance. Int J Mol Med. 12:693–700.
2003.PubMed/NCBI
|
|
48.
|
Graziano F, Mandolesi A, Ruzzo A, et al:
Predictive and prognostic role of E-cadherin protein expression in
patients with advanced gastric carcinomas treated with palliative
chemotherapy. Tumour Biol. 25:106–110. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
49.
|
Yu SJ, Yu JK, Ge WT, Hu HG, Yuan Y and
Zheng S: SPARCL1, Shp2, MSH2, E-cadherin, p53, ADCY-2 and MAPK are
prognosis-related in colorectal cancer. World J Gastroenterol.
17:2028–2036. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
50.
|
Osada S, Kanematsu M, Imai H and Goshima
S: Clinical significance of serum HGF and c-Met expression in tumor
tissue for evaluation of properties and treatment of hepatocellular
carcinoma. Hepatogastroenterology. 55:544–549. 2008.PubMed/NCBI
|
